SUSMED Competitors and Similar CompaniesClear all
CEL-SCI's competitors and similar companies include Upstream Bio and Albert Labs.
 CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ||
Founding Date | Founding Date 1983 | Founding Date 2021 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Vienna, US HQ | Locations Waltham, US HQ | Locations Burnaby, CA HQ Porto, PT Manchester, GB |
Employees | Employees N/A | Employees 38 | Employees N/A |
Valuation ($) | Valuation ($) 58.7 m | Valuation ($) 1.3 b | Valuation ($) 401.7 k |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $23m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ($20.2m) (FY, 2025) | Gross profit N/A |
Net income | Net income ($25.4m) (FY, 2025) | Net income ($143.4m) (FY, 2025) | Net income ($7.1m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Upstream Bio
HQ
Waltham, US
Employees
38
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company
Albert Labs
HQ
Burnaby, CA
Albert Labs is a clinical research and drug development company.
View company